Mitsubishi UFJ Asset Management Co. Ltd. lowered its stake in shares of InMode Ltd. (NASDAQ:INMD - Free Report) by 8.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 247,826 shares of the healthcare company's stock after selling 21,924 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd. owned about 0.36% of InMode worth $4,216,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors have also recently added to or reduced their stakes in the stock. Segall Bryant & Hamill LLC acquired a new stake in InMode in the 4th quarter valued at about $1,274,000. Fox Run Management L.L.C. purchased a new stake in shares of InMode in the fourth quarter valued at $660,000. KLP Kapitalforvaltning AS acquired a new stake in shares of InMode during the fourth quarter valued at $745,000. American Century Companies Inc. acquired a new position in InMode in the 4th quarter valued at about $299,000. Finally, Teacher Retirement System of Texas purchased a new stake in InMode in the 4th quarter worth approximately $306,000. Hedge funds and other institutional investors own 68.04% of the company's stock.
InMode Trading Down 3.6 %
INMD stock traded down $0.59 during trading on Friday, reaching $15.71. The stock had a trading volume of 2,845,043 shares, compared to its average volume of 1,177,798. The firm has a fifty day moving average price of $18.33 and a 200 day moving average price of $17.78. The company has a market capitalization of $1.09 billion, a P/E ratio of 6.69 and a beta of 1.96. InMode Ltd. has a 1-year low of $14.87 and a 1-year high of $19.99.
Wall Street Analysts Forecast Growth
A number of research firms recently issued reports on INMD. Needham & Company LLC restated a "hold" rating on shares of InMode in a report on Tuesday, February 4th. Barclays raised their price objective on InMode from $26.00 to $29.00 and gave the company an "overweight" rating in a research report on Wednesday, February 5th. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to data from MarketBeat, the company has an average rating of "Hold" and a consensus target price of $22.25.
Check Out Our Latest Stock Report on InMode
InMode Profile
(
Free Report)
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures.
Recommended Stories
Before you consider InMode, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and InMode wasn't on the list.
While InMode currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
